| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA5202696
Max Phase: Preclinical
Molecular Formula: C30H40N4O5S
Molecular Weight: 568.74
Associated Items:
Representations
Canonical SMILES: COc1ccccc1N1C(=O)CSC1c1cccc(C(=O)NCCCCN2CCN(C(=O)OC(C)(C)C)CC2)c1
Standard InChI: InChI=1S/C30H40N4O5S/c1-30(2,3)39-29(37)33-18-16-32(17-19-33)15-8-7-14-31-27(36)22-10-9-11-23(20-22)28-34(26(35)21-40-28)24-12-5-6-13-25(24)38-4/h5-6,9-13,20,28H,7-8,14-19,21H2,1-4H3,(H,31,36)
Standard InChI Key: IXORKMLBOZTXSC-UHFFFAOYSA-N
Associated Targets(Human)
HOS-TE85 154 Activities
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 568.74 | Molecular Weight (Monoisotopic): 568.2719 | AlogP: 4.54 | #Rotatable Bonds: 9 |
| Polar Surface Area: 91.42 | Molecular Species: NEUTRAL | HBA: 7 | HBD: 1 |
| #RO5 Violations: 1 | HBA (Lipinski): 9 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 1 |
| CX Acidic pKa: | CX Basic pKa: 7.23 | CX LogP: 3.44 | CX LogD: 3.22 |
| Aromatic Rings: 2 | Heavy Atoms: 40 | QED Weighted: 0.44 | Np Likeness Score: -1.30 |
References
| 1. Deng Y, Pi R, Niu L, Zhao Y, Ni D, Song L, Li Z, Han W, Wei Q, Han Y, Zhu T, Luo Z, Sun D, Dong S, Liu S.. (2022) Novel 2-phenyl-3-(Pyridin-2-yl) thiazolidin-4-one derivatives as potent inhibitors for proliferation of osteosarcoma cells in vitro and in vivo., 228 [PMID:34861640] [10.1016/j.ejmech.2021.114010] |
Source
Source(1):